期刊文献+

脓毒症患者卫气营血辨证与TNF-α、IL-10及APACHE Ⅱ评分的相关性研究 被引量:7

下载PDF
导出
摘要 目的探讨脓毒症患者卫气营血辨证分型与血清肿瘤坏死因子(TNF)-α、白介素(IL)-10水平、急性生理和慢性健康评分Ⅱ(APACHEⅡ)评分的相关性与规律性。方法纳入60例脓毒症患者,按照中医卫气营血辨证分型,分为气分证组、营分证组和血分证组。入组24 h内抽取静脉血标本,测定血清TNF-α、IL-10水平;同时进行APACHEⅡ评分,研究其相关性与规律性。结果血分证组APACHEⅡ评分、TNF-α水平均较气分证组、营分证组有明显差异(P<0.05或P<0.01),而气分证组与营分证组间差异无统计学意义(P>0.05)。3组组间IL-10水平差异不明显(P>0.05)。气分证、营分证、血分证3组脓毒症患APACHEⅡ评分与TNF-α水平呈正相关关系(r=0.83,P<0.01),与IL-10水平无相关关系(r=0.10,P=0.44)。结论各证型脓毒症患者的APACHEⅡ评分与其血清TNF-α水平呈正相关;中医卫气营血辨证有助于判断病情与体内炎症反应程度。
机构地区 江苏省中医院
出处 《中国中医急症》 2015年第3期471-472,475,共3页 Journal of Emergency in Traditional Chinese Medicine
  • 相关文献

参考文献8

  • 1Napolitano IM. Immune stimulation in sepsis to be or not to be[J]. Chest,2005,127(6) : 1882-1885. 被引量:1
  • 2Dellinger RP, Carlet JM, Masur H. Surviving sepsis campaign guide-lines for management of severe sepsis and septic shock [J ]. Crit Care Med, 2004,32 (3) : 858-873. 被引量:1
  • 3王文健,王轶宇.全身性炎症反应与中西医结合防治[J].中国中西医结合杂志,2005,25(1):68-71. 被引量:11
  • 4张丹,胡质毅,王新梅,王艳丽.脓毒症患者高迁移率族蛋白1水平与卫气营血辨证、APACHEⅡ评分的相关性研究[J].广州中医药大学学报,2009,26(3):234-236. 被引量:4
  • 5Annanc D,Bcllissant E,Cavaillon JM. Septic shock [J]. Lancet, 2005,365 (9453) : 63-78. 被引量:1
  • 6Saju R,Dinesh V,Andrew TC, et al. Intestine-specific over expression of ILL10 improves survival in polymicrobial sep2 sis [ J ]. Shock, 2008,29 (4) : 483-489. 被引量:1
  • 7Chaudhry H1 ,Zhou J,Zhong Y,et aI. Role of cytokines as a double-edged sword in sepsis[J]. In Vivo,2013,27(6) :669- 684. 被引量:1
  • 8Chuang TY, Chang HT, Chung KP, et al. High levels of serum maerophage migration inhibitory factor and interleukin 10 are associated with a rapidly fatal outcome in patients with severe sepsis[J]. Int J Infect Dis,2014,18 : 1201-1212. 被引量:1

二级参考文献23

  • 1唐建华,张荣,白朝勇,王琴,徐应抒.凡温病卫气营血证候动物模型的病理形态学观察[J].黑龙江畜牧兽医,1994(12):18-19. 被引量:5
  • 2梁华平,姚咏明,王正国.关注脓毒症及其结局的预测研究[J].中国危重病急救医学,2005,17(12):709-711. 被引量:20
  • 3Martin G S, Mannino D M, Eaton S, et al. The epidemiology of sepsis in the United States from 1979 through 2000 [J]. N Engl J Med, 2003, 348 (16): 1546. 被引量:1
  • 4Padkin A, Goldfrad C, Brady A R, et al. Epidemiology of severe sepsis occurring in the first 24 hrs in intensive care units in England, Wales, Northern Ireland [ J]. Crit Care Med, 2003, 31 (9) : 2332. 被引量:1
  • 5Knaus W A, Zimmerman J E, Wagner D P, et al. APACHE Ⅱ : a severity of disease classification system [ J]. Crit Care Med, 1985, 13 (10): 818. 被引量:1
  • 6Levy M M, Fink M P, Marshall J C, et al. 2001 SCCM/ESICM/ ACCP/ATS/SIS international sepsis conference[S]. Crit Care Med, 2003, 31 (4): 1250. 被引量:1
  • 7Wang H, Bloom O, Zbang M, et al. HMG-1 as a late mediator of endotoxin lethality in mice [ J ]. Science, 1999, 285 ( 5425 ) : 248. 被引量:1
  • 8Lotze M T, Tracey K J. High-mobility group box 1 protein ( HMGB1 ) : nuclear weapon in the immune arsenal [ J ]. Nat Rev Immunol, 2005, 5 (4): 331. 被引量:1
  • 9Yang H, Ochani M, Li J, et al. Reversing established sepsis with antagonists of endogenous high mobility group box 1 [ J ]. Proc Natl Acad Sci USA, 2004, 101 (1) : 296. 被引量:1
  • 10Sunden Cullberg J, Norrby Teglund A, Rouhiainen A, et al. Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock [ J]. Crit CareMed, 2005, 33 (3): 564. 被引量:1

共引文献13

同被引文献188

引证文献7

二级引证文献78

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部